Tianjin TEDA Biomedical Engineering Company Limited

Informe acción SEHK:8189

Capitalización de mercado: HK$511.5m

Tianjin TEDA Biomedical Engineering Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Li Sun

Chief Executive Officer (CEO)

CN¥620.1k

Compensación total

Porcentaje del salario del CEO75.6%
Permanencia del CEO9yrs
Participación del CEOn/a
Permanencia media de la dirección9yrs
Promedio de permanencia en la Junta Directiva7yrs

Actualizaciones recientes de la dirección

Recent updates

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

Oct 17
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump

There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Aug 16
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump

Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

May 07
Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Sep 12
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?

Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Apr 17
Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding

Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Apr 07
Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Nov 01
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Apr 21
Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt

Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Oct 26
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?

Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Apr 06
Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?

Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Dec 22
Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Li Sun en comparación con los beneficios de Tianjin TEDA Biomedical Engineering?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

-CN¥7m

Mar 31 2024n/an/a

-CN¥11m

Dec 31 2023CN¥620kCN¥469k

-CN¥15m

Sep 30 2023n/an/a

-CN¥24m

Jun 30 2023n/an/a

-CN¥23m

Mar 31 2023n/an/a

-CN¥28m

Dec 31 2022CN¥709kCN¥571k

-CN¥25m

Sep 30 2022n/an/a

-CN¥66m

Jun 30 2022n/an/a

-CN¥56m

Mar 31 2022n/an/a

-CN¥48m

Dec 31 2021CN¥749kCN¥620k

-CN¥42m

Sep 30 2021n/an/a

-CN¥30m

Jun 30 2021n/an/a

-CN¥42m

Mar 31 2021n/an/a

-CN¥43m

Dec 31 2020CN¥698kCN¥620k

-CN¥48m

Sep 30 2020n/an/a

-CN¥86m

Jun 30 2020n/an/a

-CN¥83m

Mar 31 2020n/an/a

-CN¥87m

Dec 31 2019CN¥728kCN¥620k

-CN¥85m

Sep 30 2019n/an/a

-CN¥133m

Jun 30 2019n/an/a

-CN¥176m

Mar 31 2019n/an/a

-CN¥174m

Dec 31 2018CN¥709kCN¥619k

-CN¥178m

Sep 30 2018n/an/a

-CN¥60m

Jun 30 2018n/an/a

-CN¥16m

Mar 31 2018n/an/a

-CN¥18m

Dec 31 2017CN¥704kCN¥619k

-CN¥14m

Compensación vs. Mercado: La compensación total de Li($USD85.61K) está por debajo de la media de empresas de tamaño similar en el mercado Hong Kong ($USD233.11K).

Compensación vs. Ingresos: La compensación de Li ha sido consistente con los resultados de la empresa en el último año.


CEO

Li Sun (50 yo)

9yrs

Permanencia

CN¥620,127

Compensación

Ms. Li Sun has been Chairman of the Board and Executive Director of Tianjin TEDA Biomedical Engineering Company Limited since August 20, 2015 and served as Chief Executive Officer since December 30, 2019 u...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Li Sun
Chairman9yrsCN¥620.13ksin datos
Xin He
Executive Director5.9yrssin datossin datos
Ka Kuen Ng
Company Secretary18.8yrsCN¥150.00ksin datos

9.0yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 8189 es experimentado (9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Li Sun
Chairman9.3yrsCN¥620.13ksin datos
Xin He
Executive Director5.9yrssin datossin datos
Jinyu Liu
Chairman of the Supervisory Committee13.3yrsCN¥124.27ksin datos
Weitao Liang
Independent Supervisor9.3yrssin datossin datos
Ximing Li
Non Executive Director7.8yrsCN¥40.00ksin datos
Chun Gao
Independent Non Executive Director7.8yrsCN¥80.00ksin datos
Yongkang Wang
Independent Non-Executive Director7yrsCN¥80.00ksin datos
Aixin Cao
Non-Executive Director7yrsCN¥220.10ksin datos
Xueying Li
Non-Executive Director3.5yrssin datossin datos
Zhiyou Zhao
Independent Supervisor2.8yrssin datossin datos
Xiangzhen Tu
Independent Non-Executive Directorless than a yearsin datossin datos

7.0yrs

Permanencia media

52.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 8189 se considera experimentada (7 años de antigüedad promedio).